High Purity Raw Materials Powders Oxytetracycline (CAS: 79-57-2)
GMP ISO 2 Inquiries
79-57-2
99%
XAZB
Foil Bag
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionProduct description
Oxytetracycline is a prescription antibiotic used to treat a wide variety of bacterial infections. This medication is predominately used to treat certain chest, eye, and genital infections, although it is sometimes used to treat severe acne as well. Some strains of bacteria have become resistant to this type of antibiotic, so it is not as widely used as it once was. Some potential side effects of oxytetracycline may include nausea, vomiting, or the development of a skin rash.Applications
Oxytetracycline is frequently used to treat bacterial infections caused by the sexually transmitted disease known as chlamydia. It may also be used to treat dental infections, Lyme disease, or pneumonia. In some cases, a doctor may order a blood culture to make sure that the particular bacteria causing the infection is not resistant to drugs such as oxytetracycline.
Oxytetracycline (terramycin) is a linear, tetracyclic broad spectrum antibiotic originally isolated from Streptomyces rimosus in 1949. Like all tetracyclines, oxytetracycline shows broad spectrum antibacterial and antiprotozoan activity and acts by binding to the 30S and 50S ribosomal sub-units, blocking protein synthesis. Oxytetracycline, although less coloured than other tetracyclines, is still a pigment and is thus sensitive to environmental and storage conditions. Commercial oxytetracycline may contain significant levels of degradation products.CertificatesBasic Info-
Product Name:
Oxytetracycline
Other Name:2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,(4S,4aR,5S,5aR,6S,12aS)-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,[4S-(4α,4aα,5α,5aα,6β,12aα)]-;(4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide;Biostat PA;5-Hydroxytetracycline;OTC;Oxymykoin;Oxyterracyne;Oxytetracycline;Riomitsin;Ryomycin;Terrafungine;Oxytetracycline amphoteric;Terramycin;Tetran;Oxyterracine;Oxitetracyclin;Oxyterracin;Vendarcin;Macocyn;Oxytetracyclin;Oxy-Kesso-Tetra;Adamycin;Proteroxyna;Berkmycen;NSC 9169;Solkaciclina;Oksisyklin;Stevacin;Fanterrin;Oxymycin;Geomycin (Streptomyces vimosus);Lenocycline;Oxypam;Liquamycin;Dabicycline;OTC (antibiotic);Teravit;Ursocycline;Liquamycin LA 200;Tarosin;Tarocyn;Ursocyclin;Geomycin;Antibiotic TM 25;Terramycin Q 50;Mycoshield TMQTHC 20;LA 200;Geotilin;TM 50;Oxyject LA;Stecsolin;Clinimycin;OXTC;Oxydon;Oxatets;Imperacin;Unimycin;Terralon LA;Stevasin;Abbocin;Oxytetral;Oxycline;Oxiter 200;Oxylim;Oxymed 50;Oxysentin 100;Erfamycin;1405-95-4;21645-09-0;52214-46-7;96310-42-8;102287-29-6;103351-03-7;105145-10-6;106216-57-3;856305-69-6;909261-39-8;1135442-00-0;1256964-22-3
CAS No.:79-57-2
Molecular Formula:C22H24N2O9
InChIKeys:InChIKey=IWVCMVBTMGNXQD-PXOLEDIWSA-N
Molecular Weight:460.43
Exact Mass:460.43
EC Number:201-212-8
HScode:30029090
Categories:
Characteristics-
PSA:
202
XLogP3:-1.6
Appearance:Beige to light yellow Crystalline Powder
Density:1.634 g/cm3 @ Temp: 20 °C
Melting Point:184-185 °C
Boiling Point:817.08°C at 760 mmHg
Flash Point:394.0±32.9 °C
Refractive Index:1.762
Water Solubility:H2O: 0.2 g/L;Sparingly soluble in aqueous solution at 0.6 mg/mL
Storage Conditions:-20°C
Vapor Pressure:9.7X10-25 mm Hg at 25 deg C (est)
Toxicity:Oral-Rat LD50: 4800 mg/kg; Oral-Mouse LD50: 2240 mg/kg
Flammability characteristics:Combustible, the fire emits nitrogen oxides and spicy irritating smoke
Specific rotation:-223 º (c=1 0.03N HCl)
PKA:3.27(at 25 °C)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Acute toxicity - Category 4, Dermal
Acute toxicity - Category 4, Inhalation
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H312 Harmful in contact with skin
H332 Harmful if inhaled
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Oxytetracycline hydrochloride preparations should be stored at a temperature less that 40 deg C, preferably between 15-30 deg C; freezing of oxytetracycline injection should be avoided. Oxytetracycline hydrochloride capsules should be stored in tight, light-resistant containers. Oxytetracycline hydrochloride
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
Egypt
Oxytetracycline Base (Injectable Grade)
1000.00 KG Mar 18, 2024 
Pakistan
Oxytetracycline
2000 TON Sep 4, 2023 Post an enquiry for this product
